Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Altus creates VP-clinical development & medical affairs

Executive Summary

Altus Pharmaceuticals appoints Alan Kimura VP-clinical development and medical affairs. The newly created will support Phase II development of the enzyme replacement therapy TheraCLEC (lipase, amylase and protease enzymes) and the long-acting human growth hormone, ALTU-238. Altus expects both products to enter Phase III next year. Since 2001, Kimura served as Transkaryotic Therapies' exec director of clinical affairs...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS045799

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel